Physician

Anna Walker Parlin, MD, MPH

According to 2025 Medicare claims, Anna Parlin, MD, MPH (NPI: 1780942722) practices ophthalmology in the Urban Honolulu, HI market, with the plurality of this provider's patient population coming from Honolulu, HI. This provider's primary affiliated billing organization is RETINA ASSOCIATES OF HAWAII, INC. (NPI: 1992759146; TIN: 990344479) and primary practice location at 96813-2412.

Parlin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 591 traditional Medicare patients, billed 18,502 HCPCS/CPT codes, and received $1,087,547 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 451 prescription claims across 121 beneficiaries totaling $79,200 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 36 records totaling $2,182. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $37,195 to $1,087,547. Similarly, Part D prescription costs have moved sharply higher in recent years, from $3,902 to $79,200. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$544K$1.1M2018 Medicare payment: $37,195 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $671,576 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $983,180 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $839,881 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $865,043 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,062,088 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,087,547 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
201855218$37,195
20194113,433$671,576
20203914,645$983,180
20214514,513$839,881
20224695,191$865,043
202351015,483$1,062,088
202459118,502$1,087,547

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$45K$89K2015 Drug cost: $3,902 (USD; Tot_Drug_Cst)2016 Drug cost: $168 (USD; Tot_Drug_Cst)2017 Drug cost: $1,895 (USD; Tot_Drug_Cst)2018 Drug cost: $2,228 (USD; Tot_Drug_Cst)2019 Drug cost: $15,587 (USD; Tot_Drug_Cst)2020 Drug cost: $33,749 (USD; Tot_Drug_Cst)2021 Drug cost: $53,860 (USD; Tot_Drug_Cst)2022 Drug cost: $64,596 (USD; Tot_Drug_Cst)2023 Drug cost: $89,105 (USD; Tot_Drug_Cst)2024 Drug cost: $79,200 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201563119$3,902
2016N/R18$168
20171565$1,895
20182050$2,228
201943112$15,587
202062240$33,749
202178337$53,860
202271312$64,596
2023118434$89,105
2024121451$79,200

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system395510$97
67028Injection of drug into eye146612$94
92012Established patient problem focused exam of visual system264802$71
92134Imaging of retina5541,555$33
92201Extended exam of the back part of the eye with retinal drawing7592$20

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium1174,987$22,760
ProlensaBromfenac Sodium502,287$18,101
IlevroNepafenac22699$8,726
Prednisolone AcetatePrednisolone Acetate654,254$3,162
DifluprednateDifluprednate151,012$1,191

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.36$2,182Sight Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Anna Walker Parlin, MD, MPH?

Tedicare shows public-source Medicare data for Anna Walker Parlin, MD, MPH (NPI 1780942722), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anna Walker Parlin, MD, MPH have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anna Walker Parlin, MD, MPH?

Anna Walker Parlin, MD, MPH is linked to RETINA ASSOCIATES OF HAWAII, INC. (billing NPI 1992759146) in the available physician profile data.

Does Anna Walker Parlin, MD, MPH have Open Payments data?

Anna Walker Parlin, MD, MPH has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.